Chongqing Xishan Science&Technology Co. Ltd. A
Chongqing Xishan Science & Technology Co., Ltd. engages in the research and development, manufacturing, sale, and service of digital minimally invasive surgical equipment and medical consumables in China and internationally. The company offers powered surgical instruments, such as micromotor, handpiece, attachment, shaver, bur, saw blade, and perforator; vacuum-assisted breast biopsy, including c… Read more
Chongqing Xishan Science&Technology Co. Ltd. A (688576) - Total Liabilities
Latest total liabilities as of June 2025: CN¥142.76 Million CNY
Based on the latest financial reports, Chongqing Xishan Science&Technology Co. Ltd. A (688576) has total liabilities worth CN¥142.76 Million CNY as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Chongqing Xishan Science&Technology Co. Ltd. A - Total Liabilities Trend (2021–2024)
This chart illustrates how Chongqing Xishan Science&Technology Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Chongqing Xishan Science&Technology Co. Ltd. A Competitors by Total Liabilities
The table below lists competitors of Chongqing Xishan Science&Technology Co. Ltd. A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nextool Technology Co. Ltd. A
SHG:688419
|
China | CN¥216.86 Million |
|
Bestore Co Ltd
SHG:603719
|
China | CN¥1.69 Billion |
|
Zhejiang Golden Eagle Co Ltd
SHG:600232
|
China | CN¥918.40 Million |
|
Guangdong Deerma Technology Co. Ltd. A
SHE:301332
|
China | CN¥1.69 Billion |
|
Taiwan Navigation Co Ltd
TW:2617
|
Taiwan | NT$8.60 Billion |
|
Citizens Inc
NYSE:CIA
|
USA | $1.52 Billion |
|
Shanghai Welltech Automation Co Ltd
SHE:002058
|
China | CN¥942.71 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down Chongqing Xishan Science&Technology Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 7.74 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.08 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Chongqing Xishan Science&Technology Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Chongqing Xishan Science&Technology Co. Ltd. A (2021–2024)
The table below shows the annual total liabilities of Chongqing Xishan Science&Technology Co. Ltd. A from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥160.75 Million | +2.12% |
| 2023-12-31 | CN¥157.41 Million | +35.50% |
| 2022-12-31 | CN¥116.17 Million | +49.07% |
| 2021-12-31 | CN¥77.93 Million | -- |